Linear Diagnostics
2 known investors
Find your way into Linear Diagnostics
Sign up to see every warm intro you have to Linear Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Linear Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Linear Diagnostics develops near-patient (point-of-care) diagnostic technology using EXPAR that delivers results in under 15 minutes, initially focused on detecting sexually transmitted infections and other infectious diseases. Its rapid testing is aimed at STI clinics to enable immediate treatment and reduce onward transmission.
Investors · 2
Frequently asked questions
- What does Linear Diagnostics do?
- Linear Diagnostics develops near-patient (point-of-care) diagnostic technology using EXPAR that delivers results in under 15 minutes, initially focused on detecting sexually transmitted infections and other infectious diseases. Its rapid testing is aimed at STI clinics to enable immediate treatment and reduce onward transmission.
- Who are Linear Diagnostics's investors?
- Linear Diagnostics's investors include Future Planet Capital, Midven Ltd..